| Title | A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion (Cadenza Study) |
|---|---|
| Disease/Condition | Hematologic Diseases,Autoimmune Diseases,Anemia,Immune System Diseases |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Irina Murakhovskaya, MD |
| Contact Name | Hieu Nguyen |
| Contact Email | hinguyen@montefiore.org |
| Protocol Number | 18-02-09-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Hematology |
| Adult, Pediatric, Both | Adult |